Met Life Investment Management, LLC Shattuck Labs, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 24,596 shares of STTK stock, worth $28,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,596
Previous 10,737 129.08%
Holding current value
$28,285
Previous $41,000 107.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.0 - $4.85 $41,577 - $67,216
13,859 Added 129.08%
24,596 $85,000
Q2 2024

Aug 13, 2024
BUY
$3.56 - $11.18 $38,223 - $120,039
10,737 New
10,737 $41,000
Q4 2021

Feb 15, 2022
SELL
$8.36 - $21.08 $91,483 - $230,678
-10,943 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$17.57 - $28.95 $192,268 - $316,799
10,943 New
10,943 $223,000
Q2 2021

May 17, 2024
BUY
$24.14 - $37.68 $114,858 - $179,281
4,758 Added 76.93%
10,943 $317,000
Q2 2021

Mar 22, 2023
BUY
$24.14 - $37.68 $114,858 - $179,281
4,758 Added 76.93%
10,943 $317,000
Q2 2021

Aug 16, 2021
BUY
$24.14 - $37.68 $114,858 - $179,281
4,758 Added 76.93%
10,943 $317,000
Q1 2021

May 17, 2024
BUY
$27.92 - $52.5 $172,685 - $324,712
6,185 New
6,185 $180,000
Q1 2021

Jun 26, 2023
BUY
$27.92 - $52.5 $172,685 - $324,712
6,185 New
6,185 $181 Million
Q4 2020

May 24, 2024
BUY
$19.0 - $57.61 $117,515 - $356,317
6,185 New
6,185 $324,000
Q4 2020

Jun 22, 2023
BUY
$19.0 - $57.61 $117,515 - $356,317
6,185 New
6,185 $324,000
Q4 2020

Mar 22, 2023
BUY
$19.0 - $57.61 $117,515 - $356,317
6,185 New
6,185 $324,000
Q4 2020

Feb 16, 2021
BUY
$19.0 - $57.61 $117,515 - $356,317
6,185 New
6,185 $324,000

Others Institutions Holding STTK

# of Institutions
80
Shares Held
28.8M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $48.7M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email